In-vitro activity of solithromycin against anaerobic bacteria from the normal intestinal microbiota
Abstract
No abstract availableKeywords
Funding Information
- Cempra, Inc.
- Scandinavian Society for Antimicrobial Chemotherapy Foundation (SLS-500871)
This publication has 14 references indexed in Scilit:
- In Vitro Activity of the New Fluoroketolide Solithromycin (CEM-101) against Macrolide-Resistant and -Susceptible Mycoplasma genitalium StrainsAntimicrobial Agents and Chemotherapy, 2014
- In Vitro Activity of Solithromycin against Erythromycin-Resistant Streptococcus agalactiaeAntimicrobial Agents and Chemotherapy, 2014
- Antimicrobial Activity of Solithromycin against Clinical Isolates of Legionella pneumophila Serogroup 1Antimicrobial Agents and Chemotherapy, 2014
- Randomized, Double-Blind, Multicenter Phase 2 Study Comparing the Efficacy and Safety of Oral Solithromycin (CEM-101) to Those of Oral Levofloxacin in the Treatment of Patients with Community-Acquired Bacterial PneumoniaAntimicrobial Agents and Chemotherapy, 2013
- Solithromycin Inhibition of Protein Synthesis and Ribosome Biogenesis in Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzaeAntimicrobial Agents and Chemotherapy, 2013
- Binding and Action of CEM-101, a New Fluoroketolide Antibiotic That Inhibits Protein SynthesisAntimicrobial Agents and Chemotherapy, 2010
- The in vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009)Journal of Infection, 2010
- Determination of CEM-101 Activity Tested against Clinical Isolates of Neisseria meningitidis from a Worldwide CollectionAntimicrobial Agents and Chemotherapy, 2010
- CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteriaDiagnostic Microbiology and Infectious Disease, 2010
- Cellular Accumulation and Pharmacodynamic Evaluation of the Intracellular Activity of CEM-101, a Novel Fluoroketolide, againstStaphylococcus aureus,Listeria monocytogenes, andLegionella pneumophilain Human THP-1 MacrophagesAntimicrobial Agents and Chemotherapy, 2009